Harbin Gloria Pharmaceuticals Co. Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 1,537.445 million compared to CNY 1,405.036 million a year ago. Operating income was CNY 150.911 million compared to CNY 816.242 million a year ago. Net income was CNY 114.586 million compared to CNY 669.009 million a year ago. Basic earnings per share from continuing operations was CNY 0.0521 compared to CNY 0.3044 a year ago.